Emergency physician versus cardiologist-initiated thrombolysis for acute myocardial infarction: A Singapore experience

Singapore Medical Journal

Volumn 45, Issue 7, 2004, Pages 313-317

  Irwani, Irwani ^a   Seet, C M ^a   Manning, P G ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Acute myocardial infarction; Door to needle time; ST elevation; ST elevation myocardial infarction (STEMI); Thrombolysis

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CARDIOLOGIST; CORONARY CARE UNIT; DOOR TO NEEDLE TIME; DRUG HYPERSENSITIVITY; EMERGENCY HEALTH SERVICE; EMERGENCY MEDICINE; EYELID EDEMA; FEMALE; FIBRINOLYTIC THERAPY; FIRST AID; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MEDICATION ERROR; PHYSICIAN; RASH; SIDE EFFECT; ST SEGMENT ELEVATION; TIME;

ADULT; AGED; AGED, 80 AND OVER; CORONARY CARE UNITS; ELECTROCARDIOGRAPHY; EMERGENCY SERVICE, HOSPITAL; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSICIANS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SINGAPORE; STREPTOKINASE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 3142586872     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Gruppo italiano per lo Studio della Streptochinasis nell'Infarcto miocardio (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; I:397-402.
2. ISIS-2 (Second International Study of Infarct Survival) collaborative group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; ii:349-60.
3. Wilcox RG, Olsson CG, Skene AM, et al for the ASSET(Anglo-Scandinavian Study of Early Thrombolysis) study group. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction (ASSET). Lancet 1988; ii:525-30.
4. The GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329:673-82.
5. Fibrinolytic therapy trialist's collaborative group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 1994; 643:311-22.
6. Rawles J. Magnitude of the benefit from earlier thrombolytic treatment in acute myocardial infarction: new evidence from Grampian region early anistreplase trial (GREAT). Br Med J 1996; 312:212-6.
7. Baigent C, Collins R, Appleby S, et al on behalf of the ISIS-2 collaborative group ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomized comparison of intravenous streptokinase, oral aspirin, both, or neither. Br Med J 1998; 316:1337-43.
8. Gruppo Italiano per lo Studio della Streptochinasi nell 'Infarto Miocardico. GISSI study group. Long term effects of intravenous thrombolysis in acute myocardial infarction: final reports of GISSI study. Lancet 1987; ii:871-4.
9. The ISAM study group. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM). Mortality, morbidity and infarct size at 21 days. N Engl J Med 1986; 314:1465-71.
10. Weaver WD. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997; 278:2110-1.
11. Zijlstra F, Hoorntje JC, de Boer MJ, Reiffers S, Miedema K, Otterv JP, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Eng J Med 1999; 341:1413-9.
12. Cucherat M, Bonnefoy E, Tremeau G. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction. Cochrane Database Syst Rev 2000; (2):CD001560.
13. D Mountain. Changing the site of delivery of thrombolytic treatment for acute myocardial infarction from coronary care unit to the emergency department greatly reduces door to needle time. Heart 2000; 84:157-63.
14. ISIS-3 (Third International Study of Infarct Survival) collaborative group. ISIS-3: randomized comparison streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 412999 cases of suspected acute myocardial infarction. Lancet 1992; 339:753-70.
15. Gruppo Italiano per lo Studio della Sopravvivenza Nell'infarto miocadico. GISSI-2: a factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12490 patients with acute myocardial infarction. Lancet 1990; 336:65-71.
16. J A Edhouse, M Sakr, J Wardrope, F P Morris. Thrombolysis in acute myocardial infarction: the safety and efficiency of treatment in the accident and emergency department. J Accid Emer Med 1999; 16:325-30.
17. Comparison of angioplasty and prehospital thrombolysis in acute myocardial infarction (CAPTIM) study group. Lancet 2002; 360:825-9.
18. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis. JAMA 2000; 283:2686-92.